PMC:7102556 / 14645-15177
Annnotations
LitCovid-PubTator
| Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
|---|---|---|---|---|---|
| 259 | 94-99 | Species | denotes | human | Tax:9606 |
| 260 | 100-104 | Species | denotes | CoVs | Tax:11118 |
| 261 | 341-344 | Species | denotes | CoV | Tax:11118 |
| 262 | 81-90 | Disease | denotes | infection | MESH:D007239 |
| 263 | 179-188 | Disease | denotes | infection | MESH:D007239 |
LitCovid-PD-FMA-UBERON
| Id | Subject | Object | Predicate | Lexical cue | fma_id |
|---|---|---|---|---|---|
| T79 | 455-468 | Body_part | denotes | cell membrane | http://purl.org/sig/ont/fma/fma63841 |
| T80 | 455-459 | Body_part | denotes | cell | http://purl.org/sig/ont/fma/fma68646 |
LitCovid-PD-MONDO
| Id | Subject | Object | Predicate | Lexical cue | mondo_id |
|---|---|---|---|---|---|
| T57 | 81-90 | Disease | denotes | infection | http://purl.obolibrary.org/obo/MONDO_0005550 |
| T58 | 179-188 | Disease | denotes | infection | http://purl.obolibrary.org/obo/MONDO_0005550 |
LitCovid-PD-CLO
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T152 | 46-49 | http://purl.obolibrary.org/obo/CLO_0051582 | denotes | has |
| T153 | 91-99 | http://purl.obolibrary.org/obo/NCBITaxon_9606 | denotes | by human |
| T154 | 328-333 | http://purl.obolibrary.org/obo/CLO_0009985 | denotes | focus |
| T155 | 390-392 | http://purl.obolibrary.org/obo/CLO_0050050 | denotes | S1 |
| T156 | 402-407 | http://purl.obolibrary.org/obo/NCBITaxon_10239 | denotes | virus |
| T157 | 437-439 | http://purl.obolibrary.org/obo/CLO_0008922 | denotes | S2 |
| T158 | 437-439 | http://purl.obolibrary.org/obo/CLO_0050052 | denotes | S2 |
| T159 | 449-454 | http://purl.obolibrary.org/obo/NCBITaxon_10239 | denotes | virus |
| T160 | 455-459 | http://purl.obolibrary.org/obo/GO_0005623 | denotes | cell |
| T161 | 460-468 | http://purl.obolibrary.org/obo/UBERON_0000158 | denotes | membrane |
LitCovid-PD-CHEBI
| Id | Subject | Object | Predicate | Lexical cue | chebi_id |
|---|---|---|---|---|---|
| T81 | 28-37 | Chemical | denotes | antiviral | http://purl.obolibrary.org/obo/CHEBI_22587 |
| T82 | 264-268 | Chemical | denotes | drug | http://purl.obolibrary.org/obo/CHEBI_23888 |
| T83 | 437-439 | Chemical | denotes | S2 | http://purl.obolibrary.org/obo/CHEBI_29387 |
LitCovid-PD-GO-BP
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T39 | 460-475 | http://purl.obolibrary.org/obo/GO_0061025 | denotes | membrane fusion |
| T40 | 509-526 | http://purl.obolibrary.org/obo/GO_0019079 | denotes | viral replication |
| T41 | 509-526 | http://purl.obolibrary.org/obo/GO_0019058 | denotes | viral replication |
LitCovid-sentences
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T91 | 0-105 | Sentence | denotes | At the present, no specific antiviral therapy has been approved for treatment of infection by human CoVs. |
| T92 | 106-314 | Sentence | denotes | As development of vaccines and compounds for prevention and treatment of infection have been brought to priority status by WHO and governments [56], numerous drug studies have been done or are moving forward. |
| T93 | 315-532 | Sentence | denotes | Some of them focus on the CoV fusion/entry process either by inhibition of S1 mediated virus attachment or by blocking of S2 mediated virus-cell membrane fusion, and some of them interfere with viral replication [57]. |
2_test
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| 32017984-30261226-69697764 | 250-252 | 30261226 | denotes | 56 |
| 32017984-29143192-69697765 | 528-530 | 29143192 | denotes | 57 |